A Phase 1 interventional study of Cognitive Therapy in Suicide, Attempted, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to male participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2015-04-08.
Sponsored by University of Pennsylvania · Phase 1, Interventional, and Treatment
This study will assess the effectiveness of cognitive therapy in reducing the incidence of suicide ideation and behavior in older men in a primary care setting.
Older adult males have the highest suicide rate of any age group in the U.S. Over 70 percent of older suicide victims have been to their primary care physician within a month of their death, many with a depressive illness that was not detected. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 60 and above. This study will assess the effectiveness of specialized cognitive therapy versus typical treatment in treating older men with suicide ideation.
Participants in this two-year, single-blind study will be randomly assigned to receive either cognitive therapy combined with enriched care or enriched care alone. Participants will be identified in primary care settings as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enriched care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 12, 18, and 24 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.
For information on a related study, please follow this link:
http://clinicaltrials.gov/show/NCT00218725
701 studies on the registry are indexed under Suicide; 183 are open to participants now.
This study's enrollment of 34 is below the median of 104 across 560 interventional studies indexed under Suicide.
Browse Suicide studies →University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.
Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The cognitive therapy intervention consists of approximately 12 (1-hour) sessions over the course of a 4-month period. The main therapy components include: 1. Using problem-solving and cognitive restructuring techniques to target hopelessness, reasons for living and dying, coping with loss, and perceived medical comorbidity that lead to suicidal ideation. 2. Improving social resources. 3. Improving adherence to medical regimen. 4. Targeting Suicidal Cognitions.
Behavioral: Cognitive Therapy
The Enriched Care (EC) condition will be used as the treatment comparison for this study. EC consists of usual care patients may obtain in the community as well as the assessment and referral services provided by the study case managers. Participation in the study does not restrict patients in any way in their access to other health care, and all patients in both conditions will be allowed to receive any additional mental health treatment in the community. The primary role of the study case manager is to establish a strong relationship with patients in order to retain the patients in the study for the duration of the study period.
Suicidal Ideation; measured at Months 1, 3, 6, 12, 18, and 24
Time frame: 1, 3, 6, 12, 18, and 24 months
Depression; measured at Months 1, 3, 6, 12, 18, and 24
Time frame: 1, 3, 6, 12, 18, and 24 months
Hopelessness; measured at Months 1, 3, 6, 12, 18, and 24
Time frame: 1, 3, 6, 12, 18, and 24 months
Perceived Social Support; measured at Months 1, 3, 6, 12, 18, and 24
Time frame: 1, 3, 6, 12, 18, and 24 months
This study is completed, as verified in Jun 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Pennsylvania